Stocks: Catching the Market Blues

Gopal,Kevin;

Article

Pharmaceutical Executive

June 1, 2001

Pharmaceutical Executive

Pharmaceutical Executive-06-01-2001

Volume0

Issue 0

Stocks: Catching the Market Blues

Author(s):

Kevin Gopal

Buckinghamshire, UK-The pharma industry may be countercyclical, but it’s not immune to market trends. Nycomed Amersham recently postponed a partial US stock flotation of its life sciences company, ABBiotech, because of market weakness.

Articles in this issue

Industry Under Investigation

Emotion - The New Brand Integrator

For Love of the Game

Field of Dreams

Workshop: Access Options

Emotion - The New Brand Integrator

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Stocks: Catching the Market Blues

Newsletter